Form Type: 4

SEC EDGAR Link
Acccession Number:0001225208-19-013983
Date:2019-10-31
Issuer: PFIZER INC (PFE)
Original Submission Date:

Reporting Person:

BOURLA ALBERT
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST. NEW YORK, NY 10017

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
PHANTOM STOCK UNITS SSP 0.0 2019-10-31 deemed execution date A 26 (a) common stock 26 $0.00 72,199 direct
Footnotes
IDfootnote
f1 each unit represents one phantom share of common stock.
f2 these units, which were acquired pursuant to the pfizer supplemental savings plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Elevate your investments